Opioid-Related Disorders

"Opioid-Related Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Disorders related or resulting from abuse or mis-use of opioids.

Descriptor ID	D009293
MeSH Number(s)	C25.775.675 F03.900.675
Concept/Terms	Opioid-Related Disorders Opioid-Related Disorders Disorder, Opioid-Related Opioid Abuse Abuse, Opioid Abuses, Opioid Opioid Abuses Opiate Abuse Abuse, Opiate Abuses, Opiate Opiate Abuses Opiate Dependence Opiate Dependence Dependence, Opiate Opiate Addiction Addiction, Opiate

Below are MeSH descriptors whose meaning is more general than "Opioid-Related Disorders".

Diseases [C]
Chemically-Induced Disorders [C25]
Substance-Related Disorders [C25.775]
Opioid-Related Disorders [C25.775.675]
Psychiatry and Psychology [F]
Mental Disorders [F03]
Substance-Related Disorders [F03.900]
Opioid-Related Disorders [F03.900.675]

Below are MeSH descriptors whose meaning is related to "Opioid-Related Disorders".

Below are MeSH descriptors whose meaning is more specific than "Opioid-Related Disorders".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Opioid-Related Disorders" by people in this website by year, and whether "Opioid-Related Disorders" was a major or minor topic of these publications.

Bar chart showing 79 publications over 17 distinct years, with a maximum of 23 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	1	0	1
2004	1	0	1
2008	2	1	3
2009	0	2	2
2010	1	0	1
2012	3	0	3
2013	1	0	1
2014	5	0	5
2015	1	0	1
2016	2	0	2
2017	3	0	3
2018	5	0	5
2019	14	0	14
2020	22	1	23
2021	8	0	8
2022	4	0	4
2023	2	0	2

Below are the most recent publications written about "Opioid-Related Disorders" by people in Profiles.

Smit T, Mayorga NA, Rogers AH, Woods SP, Heggeness LF, Kauffman BY, Garey L, Zvolensky MJ. Indirect Effects of Negative Mood on Opioid Misuse and Dependence via Anxiety Sensitivity Subfacets: Evidence from Adults Reporting Chronic Pain. Subst Use Misuse. 2023; 58(4):570-577.

View in: PubMed
Tabatabai M, Cooper RL, Wilus DM, Edgerton RD, Ramesh A, MacMaster SA, Patel PN, Singh KP. The Effect of Naloxone Access Laws on Fatal Synthetic Opioid Overdose Fatality Rates. J Prim Care Community Health. 2023 Jan-Dec; 14:21501319221147246.

View in: PubMed
Punches BE, Stolz U, Freiermuth CE, Ancona RM, McLean SA, House SL, Beaudoin FL, An X, Stevens JS, Zeng D, Neylan TC, Clifford GD, Jovanovic T, Linnstaedt SD, Germine LT, Bollen KA, Rauch SL, Haran JP, Storrow AB, Lewandowski C, Musey PI, Hendry PL, Sheikh S, Jones CW, Kurz MC, Gentile NT, McGrath ME, Hudak LA, Pascual JL, Seamon MJ, Harris E, Chang AM, Pearson C, Peak DA, Merchant RC, Domeier RM, Rathlev NK, O'Neil BJ, Sanchez LD, Bruce SE, Pietrzak RH, Joormann J, Barch DM, Pizzagalli DA, Smoller JW, Luna B, Harte SE, Elliott JM, Kessler RC, Ressler KJ, Koenen KC, Lyons MS. Predicting at-risk opioid use three months after ed visit for trauma: Results from the AURORA study. PLoS One. 2022; 17(9):e0273378.

View in: PubMed
Smit T, Mayorga NA, Rogers AH, Nizio P, Zvolensky MJ. Chronic pain acceptance: Relations to opioid misuse and pain management motives among individuals with chronic low back pain. Addict Behav. 2023 01; 136:107495.

View in: PubMed
Livingston CJ, Berenji M, Titus TM, Caplan LS, Freeman RJ, Sherin KM, Mohammad A, Salisbury-Afshar EM. American College of Preventive Medicine: Addressing the Opioid Epidemic Through a Prevention Framework. Am J Prev Med. 2022 09; 63(3):454-465.

View in: PubMed
Hassan R, Roland KB, Hernandez B, Goldman L, Evans KN, Gaul Z, Agnew-Brune C, Buchacz K, Fukuda HD. A qualitative study of service engagement and unmet needs among unstably housed people who inject drugs in Massachusetts. J Subst Abuse Treat. 2022 07; 138:108722.

View in: PubMed
Santiago D, Rosario Y, Melin K, Duconge J, Roman L, Gonzalez A, Venkataramanan R. Brand-to-Generic Substitution of Buprenorphine/Naloxone Sublingual Film in Puerto Rico: A Case Study. P R Health Sci J. 2021 12; 40(4):192-194.

View in: PubMed
Berry ARW, Finlayson TL, Mellis LM, Urada LA. Association between Participation in Counseling and Retention in a Buprenorphine-Assisted Treatment Program for People Experiencing Homelessness with Opioid Use Disorder. Int J Environ Res Public Health. 2021 10 21; 18(21).

View in: PubMed
Rahman S, Rahman ZI, Ronan PJ, Lutfy K, Bell RL. Adolescent opioid abuse: Role of glial and neuroimmune mechanisms. Int Rev Neurobiol. 2022; 161:147-165.

View in: PubMed
Qui?ones DS, Melin K, Roman L, Rodriguez F, Alvarado J, Rodr?guez-D?az CE. Treating Opioid Use Disorder in Puerto Rico During the COVID-19 Pandemic: Providers' Leadership Efforts in Unprecedented Times. J Addict Med. 2021 Jul-Aug 01; 15(4):276-279.

View in: PubMed

People

Explore

Similar Concepts

Top Journals